Total combined global risk assessment applied to pharmaceutical equivalence –a case study of ofloxacin medicines (2023)
- Authors:
- USP affiliated authors: LOURENÇO, FELIPE REBELLO - FCF ; CAFFARO, ARTHUR MASSABKI - FCF
- Unidade: FCF
- DOI: 10.1016/j.chemolab.2023.104935
- Assunto: FÁRMACOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Chemometrics and Intelligent Laboratory Systems
- ISSN: 0169-7439
- Volume/Número/Paginação/Ano: v. 241, p. 1-9 art. 104935, 2023
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
CAFFARO, Arthur Massabki e LOURENÇO, Felipe Rebello. Total combined global risk assessment applied to pharmaceutical equivalence –a case study of ofloxacin medicines. Chemometrics and Intelligent Laboratory Systems, v. 241, p. 1-9 art. 104935, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.chemolab.2023.104935. Acesso em: 19 fev. 2026. -
APA
Caffaro, A. M., & Lourenço, F. R. (2023). Total combined global risk assessment applied to pharmaceutical equivalence –a case study of ofloxacin medicines. Chemometrics and Intelligent Laboratory Systems, 241, 1-9 art. 104935. doi:10.1016/j.chemolab.2023.104935 -
NLM
Caffaro AM, Lourenço FR. Total combined global risk assessment applied to pharmaceutical equivalence –a case study of ofloxacin medicines [Internet]. Chemometrics and Intelligent Laboratory Systems. 2023 ; 241 1-9 art. 104935.[citado 2026 fev. 19 ] Available from: https://doi.org/10.1016/j.chemolab.2023.104935 -
Vancouver
Caffaro AM, Lourenço FR. Total combined global risk assessment applied to pharmaceutical equivalence –a case study of ofloxacin medicines [Internet]. Chemometrics and Intelligent Laboratory Systems. 2023 ; 241 1-9 art. 104935.[citado 2026 fev. 19 ] Available from: https://doi.org/10.1016/j.chemolab.2023.104935 - Quality assessment of medicines based on consumer’s and producer’s risk estimation
- Setting multivariate and correlated acceptance limits for assessing the conformity of items
- Doseamento microbiológico de gentamicina por difusão em agar-proposta de delineamento experimental
- Frequentist approach for estimation of false decision risks in conformity assessment based on measurement uncertainty of liquid chromatography analytical procedures
- Application of measurement uncertainty on conformity assessment in pharmaceutical drug products
- Top-down evaluation of the matrix effects in microbial enumeration test uncertainty
- Development and optimization of a stability-indicating chromatographic method for verapamil hydrochloride and its impurities in tablets using an analytical quality by design (AQbD) approach
- Reduced incubation time for inhibition zone formation based on diffusion and growth mechanism elucidation
- Measurement uncertainty in pharmaceutical analysis and its application
- In vitro therapeutic equivalence of ciprofloxacin ophthalmic drugs based on measurement uncertainty and Monte Carlo simulations
Informações sobre o DOI: 10.1016/j.chemolab.2023.104935 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
3155559.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
